Seizing the digital opportunities in pharma


Preparing your organization and monetizing the digital technologies

Digitalization in healthcare is booming, and creates unprecedented opportunities to further improve health standards and accessibility. Still, large pharma companies are confronted with the challenge of selecting, funding and developing the right projects among myriad initiatives: What is the right starting point and framework to compete?

What to prioritize? How to make digital pervasive in the organization? How to monetize it?
Based on our recent experience, we at Arthur D. Little have developed a pragmatic framework to characterize and evaluate the opportunities, define and prioritize the related initiatives, and ensure that there is a clear business rationale – along with its financial business case – supporting them.
We share below some of the learnings from our recent work with pharmaceutical companies in this area.

Released: October 2017

Download File ADL_Seizing_the_digital_opportunities_in_pharma.pdf (.PDF, 688 Kb)

« previous report | next report »

« back